Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26462
Abstract: To evaluate the cost‐effectiveness of letermovir versus no prophylaxis for the prevention of cytomegalovirus infection and disease in adult cytomegalovirus‐seropositive allogeneic hematopoietic cell transplantation (allo‐HCT) recipients. A decision model for 100 patients was developed to… read more here.
Keywords: analysis; cytomegalovirus; prophylaxis; cytomegalovirus prophylaxis ... See more keywords